Safety evaluation of exosomes derived from human umbilical cord mesenchymal stromal cell

详细信息    查看全文

• 作者：Li Sun¹ ; Rongman Xu¹ ; Xiaoxian Sun¹ ; Yuping Duan¹ ; Yiwen Han¹ ; Yuanyuan Zhao¹ ; Hui Qian¹ ; Wei Zhu¹ ; ² ; ^{zhuwei@ujs.edu.cn" class="auth_mail" title="E-mail the corresponding author} ; Wenrong Xu¹ ; ² ; ^{icls@ujs.edu.cn" class="auth_mail" title="E-mail the corresponding author}
• 关键词：exosomes ; human umbilical cord ; mesenchymal stromal cell ; safety
• 刊名：Cytotherapy
• 出版年：2016
• 出版时间：March 2016
• 年：2016
• 卷：18
• 期：3
• 页码：413-422
• 全文大小：1922 K

文摘

Mounting evidence shows that non–cell-based transplantation of exosomes derived from mesenchymal stromal cells (MSCs) has more potential protective and reparative effects than MSCs have. However, whether it is safe to transplant MSC exosomes into tissues is still not clear. In this study, we evaluated the safety of transplantation of exosomes derived from human umbilical cord MSCs (hucMSC exosomes).

Methods

hucMSC exosomes were incubated with the cardiac blood from a healthy rabbit, and hemolysis was observed. For analysis of vascular and muscle stimulation, pyrogen, systemic anaphylaxis and hematology indexes, hucMSC exosomes were given to rabbits, guinea pigs and rats. The histological changes in the vascular and muscle sites of injection in rabbits were analyzed by hematoxylin and eosin staining. Allergy symptoms in guinea pigs and rectal temperature of rabbits were observed and recorded. To study safety in vivo, hucMSC exosomes were infused intravenously into rats with acute myocardial infarction. Rats' weight was measured and tail vein blood was collected to evaluate liver and renal function.

Results

hucMSC exosomes had a protective effect on weight loss and had no adverse effects on liver or renal function. Other detections, such as hemolysis, vascular and muscle stimulation, systemic anaphylaxis, pyrogen and hematology indexes, also showed that hucMSC exosomes were applicable.

Conclusions

hucMSC exosomes are well tolerated in animal models. This study provides evidence for the safety of intravenous infusion in future clinical therapy.